When was Revolution Medicines founded?

Revolution Medicines was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is Revolution Medicines located?

Revolution Medicines is headquartered in Redwood City, United States. It is registered at Redwood City, California.

How many employees does Revolution Medicines have?

As of Sep 30, 2026, the latest employee count at Revolution Medicines is 1468.

Is Revolution Medicines a funded company?

Revolution Medicines is a funded company, having raised a total of $326M across 5 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Feb 04, 2015.

When was the latest funding round of Revolution Medicines?

Revolution Medicines' latest funding was a $***** Series C round on Nov 13, 2019, with participation from 1 investor.

What is the annual revenue of Revolution Medicines?

Annual revenue of Revolution Medicines is between $10M and $50M as on Dec 31, 2023

Where does Revolution Medicines rank among its competitors?

Revolution Medicines ranks 96th amongst 3384 active competitors, of which 1127 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Sana Biotechnology, which secured $25M in Aug, 2026.

Who are the top competitors of Revolution Medicines?

Revolution Medicines' top competitors include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Among them, Sana Biotechnology secured the most recent funding round in August, 2026.

Revolution Medicines - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of therapies for the treatment of cancer. The company's product line include RMC-4630, is a selective inhibitor of SHP2, a central node in the RAS signaling pathway and RMC-5552, is a selective inhibitor of mTORC1, is designed to prevent inactivation of the tumor-suppressive properties of a protein.

Website: revmed.com
Email ID: *****@revmed.com
Phone Number: +1 **********
Registered Address: Redwood City, California

Key Metrics

Founded Year

2014

Location

Redwood City, United States

Stage

Public

Total Funding

$326M in 5 rounds

Latest Funding Round

Series C, Nov 13, 2019, $*****

Investors

Third Rock Ventures & 16 more

Ranked

96^th among 3384 active competitors

Annual Revenue

$10M - $50M as on Dec 31, 2023

Employee Count

1,468 as on Sep 30, 2026

Investment & Acquisitions

EQRx & 1 more

Similar Companies

Jazz Pharmaceuticals & 3013 more

Exit Details

Public

View Revolution Medicines' full profile

Revolution Medicines is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Revolution Medicines, Inc. CIN: 1628171 , United States, Active	Oct 06, 2014	$10M - $50M (As on Dec 31, 2023)	-	-
REVOLUTION MEDICINES INC CIN: 472029180 , United States, Active	Dec 31, 1999	-	513 (As on Dec 31, 2024)	-
Revolution Medicines Inc. CIN: 5611600 , United States, Active		-	51 (As on Dec 31, 2017)	-

Revolution Medicines got listed on Feb 13, 2020.

Click here to take a look at Revolution Medicines's IPO in detail

Revolution Medicines has raised a total funding of $326M over 5 rounds. Its first funding round was on Feb 04, 2015. Its latest funding round was a Series C round on Nov 13, 2019 for $*****. 1 investor participated in its latest round. Revolution Medicines has 17 institutional investors.

Here is the list of recent funding rounds of Revolution Medicines:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 13, 2019	2589226	Series C	7278992	6013507	4319345	4514410
Jul 09, 2019	9763977	Series C	5005183	4301959	7392765	Cormorant Capital & 7 more
Apr 24, 2018	8638508	Series B	1088960	7161722	Nextech Invest	Casdin Capital & 3 more

Access funding benchmarks and valuations. Sign up today!

View details of Revolution Medicines's funding rounds and investors

The founders of Revolution Medicines are Kevan Shokat and Michael Fischbach.

Here are the details of Revolution Medicines' key team members:

Kevan Shokat: Co-Founder of Revolution Medicines.
Michael Fischbach: Co-Founder of Revolution Medicines.
Contact Info: 1 email address

View details of Revolution Medicines's Founder profiles and Board Members

Revolution Medicines' employee count trend

Revolution Medicines has 1,468 employees as of Sep 26. Here is Revolution Medicines's employee count trend over the years:

Employee count trend for Revolution Medicines

Uncover Revolution Medicines' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Revolution Medicines include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Here is the list of Top 10 competitors of Revolution Medicines, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	81/100
2nd	BeiGene 2010, Cambridge (United States), Public	Developer of targeted and immune-oncology drugs against cancer	$172M	Hillhouse, T. Rowe Price & 13 others	81/100
3rd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, PSP Investments & 18 others	74/100
4th	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	73/100
5th	Senti Bio 2016, San Francisco (United States), Public	Developer of cell and gene therapies for patients living with incurable diseases	$158M	Celadon Partners, Leaps by Bayer & 30 others	72/100
6th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
7th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
8th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	F-Prime Capital, True North & 23 others	72/100
9th	Moderna 2010, Cambridge (United States), Public	Developer of mRNA-based therapeutics for a wide range of diseases	$2.78B	Merck, AstraZeneca & 32 others	72/100
10th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
96th	Revolution Medicines 2014, Redwood City (United States), Public	Developer of therapies for the treatment of cancer	$326M	HTIF, Colt Ventures & 15 others	65/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Revolution Medicines's competitors? Click here to see the top ones

Revolution Medicines has acquired 2 companies including EQRx and Warp Drive Bio. Revolution Medicines has not made any investments as of now.

Here is the latest report on Revolution Medicines's sector:

Free

Oncology - Sector Report

Edition: August, 2026 (74 Pages)

View all reports related to Revolution Medicines

Media has covered Revolution Medicines for a total of 58 events in the last 1 year, 34 of them have been about company updates and 2 about partnerships.